What Does a Heterogeneous Myometrium Mean?

A heterogeneous myometrium means the muscular wall of the uterus looks uneven on an ultrasound scan, with a mix of lighter and darker areas instead of the smooth, uniform texture a healthy myometrium typically shows. The finding most commonly points toward adenomyosis, a condition in which tissue that normally lines the inside of the uterus grows into the muscle layer itself. Less often, fibroids, prior surgery, or rare vascular abnormalities can produce a similar ultrasound appearance, so context matters when your doctor explains the report.

Why Adenomyosis Is Usually the Explanation

When a radiologist or sonographer writes “heterogeneous myometrium” in a report, adenomyosis is the diagnosis they are thinking about most of the time. A study comparing ultrasound and MRI features of adenomyosis found that heterogeneous myometrium was the most common and consistently useful ultrasound sign for diagnosing the condition, outperforming other individual markers.¹ In a separate clinical series of women evaluated for adenomyosis, roughly three out of four had a heterogeneous myometrium on their ultrasound.²

So what is actually happening inside the uterus? In adenomyosis, normal-appearing endometrial tissue, the same kind that lines the uterine cavity and sheds during a period, ends up embedded within the myometrium. Because this tissue is buried in muscle, it cannot shed the way it would during menstruation. The trapped tissue disrupts the normal architecture of the muscle, and those disruptions are what create the patchy, uneven texture on ultrasound.³ The ectopic glands and surrounding tissue can also interfere with the normal rhythmic contractions of the uterine muscle, which helps explain the heavy, painful periods that many women with adenomyosis experience.

Fibroids and Other Structural Causes

Adenomyosis is not the only explanation for an uneven-looking uterine wall. Uterine fibroids, which are benign smooth-muscle tumors, can also make the myometrium look heterogeneous, especially when multiple small fibroids are scattered throughout the muscle rather than forming a single obvious mass. In fact, the two conditions frequently coexist. In the clinical series mentioned earlier, about two thirds of the women with adenomyosis also had fibroids.² That overlap can make interpretation tricky, because a radiologist looking at an ultrasound may see a mixture of changes from both conditions at once.

Prior cesarean sections or other uterine surgeries can leave scarring in the myometrium that alters its echogenicity, the way it bounces back sound waves. Uterine arteriovenous malformations, though rare, produce their own kind of heterogeneity. These vascular tangles can appear on grayscale ultrasound as small tubular structures or spongy-looking areas within the muscle wall, and are typically confirmed with Doppler imaging and CT angiography.⁴ These are uncommon enough that they are not the first thing a clinician considers, but they matter because treatment is entirely different from adenomyosis management.

Could It Be Cancer?

This is the question that keeps people up at night after reading their ultrasound report, so it is worth addressing directly. Uterine sarcomas, the malignant tumors that arise from the muscle wall itself, are rare. When they do occur, they tend to look different from benign heterogeneity. Sarcomas typically present as large isolated masses with rich blood flow running through them and sometimes cystic areas inside the tumor. One study of malignant myometrial tumors found they had an average diameter of about 91 millimeters and showed uneven internal echoes in roughly three quarters of cases, sometimes with irregular fluid-filled spaces.⁵ Rapid growth of a uterine mass is another red flag that distinguishes sarcoma from benign fibroids or adenomyosis.⁶

A diffusely heterogeneous myometrium without a dominant mass, without heavy internal blood flow, and without rapid enlargement is a very different picture from a sarcoma. If your report describes scattered heterogeneity across the uterine wall rather than a single large, highly vascular lesion, the likelihood of malignancy is low. That said, your doctor may order additional imaging or follow-up scans to be thorough, which is a reasonable and standard response.

Endometrial cancer is a separate consideration. It arises from the lining of the uterus rather than the muscle, but advanced stages can invade into the myometrium. Researchers are developing deep-learning models that analyze ultrasound images to predict the depth of myometrial invasion in endometrial cancer, aiming to help surgeons plan treatment without relying solely on MRI.⁷ This is still an emerging tool, but it underscores how much information about the myometrium can be extracted from ultrasound when the right analytical methods are applied.

When the Finding Is a False Alarm

Not every instance of a heterogeneous-looking myometrium reflects a permanent structural problem. The uterus is a dynamic organ, and its muscular wall contracts and relaxes throughout the menstrual cycle and during other physiological states. Researchers have documented that transient, non-cyclical contractions of the outer myometrium can temporarily change how the uterine wall looks on ultrasound, potentially mimicking the appearance of adenomyosis or even structural anomalies.⁸ If the scan catches the uterus mid-contraction, the myometrium can look temporarily thickened or uneven in a way that resolves on its own within minutes.

This is one reason experienced sonographers sometimes take their time during a scan or ask you to return at a different point in your cycle. A finding of heterogeneous myometrium on a single scan, especially a quick or technically limited one, is not always the final word. If the clinical picture does not match, meaning you have no heavy bleeding, no pelvic pain, no fertility issues, your doctor may recommend a repeat scan before jumping to a diagnosis of adenomyosis.

Sorting It Out With MRI and Doppler

Standard two-dimensional ultrasound is the first-line imaging tool for the uterus, and it is good at raising suspicion for adenomyosis. But when the diagnosis is uncertain or the clinical stakes are high, such as before a fertility procedure or a planned surgery, doctors often reach for more advanced imaging.

MRI gives the clearest view of a structure called the junctional zone, the inner boundary layer between the endometrium and the myometrium. In adenomyosis, this zone becomes abnormally thick. A junctional zone of at least 12 millimeters on MRI is the most widely used threshold for diagnosing adenomyosis.⁹ In one study, women with adenomyosis had an average junctional zone thickness of about 14 millimeters, compared to roughly 6 millimeters in women without the condition.¹⁰ More recent work suggests the real hallmark is not just a thicker zone overall, but actual interruptions where endometrial tissue pushes into the muscle, creating small buds or lines visible on detailed imaging.¹¹

When differentiating adenomyosis from fibroids is the goal, three-dimensional ultrasound with Doppler blood-flow analysis is another powerful option. Fibroids tend to have blood vessels running around their edges, while adenomyosis tends to show blood flow concentrated centrally within the affected area. One study using these techniques found that central blood flow was present in over 90% of adenomyosis cases, and an ill-defined junctional zone on 3D ultrasound appeared in about 86%.¹² The same study reported sensitivity above 95% and specificity above 93% for diagnosing adenomyosis when Doppler criteria were applied, meaning these tools are quite reliable at telling the two conditions apart.

How Adenomyosis Affects Fertility and Pregnancy

If you are trying to conceive and your ultrasound shows a heterogeneous myometrium, the fertility implications depend on what is causing it. Adenomyosis, the most common explanation, does appear to reduce the odds of becoming pregnant and increase the risk of complications once you are pregnant. A systematic review combining data from multiple studies found that women with adenomyosis undergoing assisted reproduction had roughly 30% lower odds of a clinical pregnancy and more than double the odds of miscarriage compared to women without the condition.¹³

The risks extend beyond getting pregnant. A study comparing pregnancy outcomes in women with and without adenomyosis found a 42% increase in the risk of preterm delivery among those with the condition.¹⁴ The junctional zone itself seems to play a role in this risk. A separate study found that women with a thicker junctional zone had nearly twice the odds of spontaneous preterm labor, even after accounting for other factors like age and body weight.¹⁵

These numbers do not mean pregnancy is impossible with adenomyosis. Many women with the condition carry pregnancies successfully. But the data do suggest that if you are planning a pregnancy and adenomyosis has been identified, closer monitoring may be worthwhile. Some fertility specialists treat adenomyosis with hormonal suppression before an IVF cycle in an effort to quiet the disease, though the evidence on whether this consistently improves outcomes is still evolving.

What Symptoms Usually Accompany the Finding

A heterogeneous myometrium is an imaging observation, not a symptom. Plenty of women learn about it only because they had a pelvic ultrasound for some other reason and the finding showed up incidentally. Whether it causes trouble depends on the underlying condition and its severity.

When adenomyosis is responsible, the classic symptoms are heavy menstrual bleeding and painful periods that tend to worsen over time. The trapped endometrial tissue within the muscle disrupts normal contractions and can create localized inflammation, both of which contribute to prolonged or excessive bleeding.³ Some women also experience chronic pelvic pain between periods, pain during intercourse, or a sensation of pelvic pressure as the uterus enlarges. Fibroids can produce a similar constellation of symptoms, which is part of why imaging is so important for distinguishing the two.

Mild adenomyosis can be entirely silent. If your ultrasound shows a slightly heterogeneous myometrium but you have no bothersome symptoms, your doctor may recommend monitoring rather than immediate treatment. The presence of the finding alone does not obligate you to do anything about it unless it is affecting your quality of life or your reproductive plans.

What the Uterus Looks Like After Treatment

If you end up being treated for fibroids or adenomyosis with uterine artery embolization, a minimally invasive procedure that cuts off blood supply to the problem areas, the ultrasound appearance of your uterus will change over the following months. Treated fibroids typically shrink by 40% to 70% in volume within six months, lose their central blood flow, and appear more uniformly dark on ultrasound. Adenomyosis features, including thickening of the junctional zone and overall myometrial thickening, may also diminish after embolization.¹⁶

One useful insight from post-treatment imaging is that persistent blood flow inside a treated fibroid or adenomyoma correlates with ongoing symptoms. A review of over 100 embolization cases found a significant link between residual vascularity on follow-up ultrasound and the patient seeking further treatment because symptoms had not resolved.¹⁶ If your follow-up scan still shows blood flowing into the treated area, it may be a sign that additional intervention is needed. Conversely, a treated area that looks darker and avascular is generally a good prognostic sign, even if the myometrium still appears somewhat heterogeneous in texture for a while as the tissue remodels.

Why Distinguishing Adenomyosis From Fibroids Changes Your Options

At first glance, these two conditions can seem interchangeable: both cause heavy bleeding, both can make the uterus look uneven on imaging, and both respond to some of the same hormonal treatments. But the practical management paths diverge in meaningful ways, which is why your doctor cares about telling them apart.

Fibroids are discrete growths with defined borders. That makes them candidates for targeted surgical removal, a procedure called myomectomy, which can preserve the uterus and fertility. Adenomyosis, by contrast, is diffuse. The abnormal tissue is woven into the muscle itself, making it far harder to cut out without removing significant amounts of healthy myometrium. When adenomyosis is severe and a woman has completed childbearing, hysterectomy remains the only definitive cure, though hormonal medications and uterine artery embolization can manage symptoms in the meantime.

The blood-flow patterns on Doppler ultrasound are one of the clearest ways to distinguish the two. Fibroids show vessels wrapping around their periphery, while adenomyosis shows flow running through the center of the affected tissue.¹² Knowing which condition you have also changes the conversation about fertility. A woman with a single large fibroid distorting her uterine cavity might be an excellent candidate for surgical removal before an IVF cycle, whereas a woman with diffuse adenomyosis might benefit more from a period of hormonal suppression to quiet the disease before embryo transfer. The ultrasound finding of a heterogeneous myometrium is the starting point for that entire decision tree.

The Hormonal Connection

Both adenomyosis and fibroids are estrogen-dependent conditions, which is why they tend to develop during the reproductive years and often improve after menopause when estrogen levels fall. This hormonal link has practical consequences. Hormonal therapies that suppress estrogen, including certain oral contraceptives, progestins, and GnRH agonists, can reduce the severity of adenomyosis symptoms and sometimes slow its progression.

Hormone replacement therapy after menopause introduces a wrinkle. If a postmenopausal woman is taking estrogen, there is a theoretical concern that it could fuel the persistence of adenomyosis or reactivate it. While some studies have looked at HRT’s effects on the endometrium, the data on myometrial changes specifically are limited. One retrospective study of HRT users found no significant difference in endometrial thickness compared to non-users, but endometrial thickness and myometrial heterogeneity are different measurements, and the study was not designed to address adenomyosis directly.¹⁷ If you are on HRT and your ultrasound shows a heterogeneous myometrium, it is worth discussing with your doctor whether the finding warrants any change in your regimen, though in many cases it will be a leftover signature from adenomyosis that was present before menopause rather than something newly developing.

1
The Egyptian Journal of Radiology and Nuclear Medicine. What are the most reliable signs for the radiologic diagnosis of uterine adenomyosis? An ultrasound and MRI prospective – Section: 3. Results
2
PubMed Central. Adenomyosis: Back to the future?
3
PubMed Central. Pathology and Pathogenesis of Adenomyosis
4
PubMed Central. Sonographic Features of Uterine Arteriovenous Malformation: A Case Series
5
Glob Libr Women’s Med. Ultrasound Differentiation of Malignant Myometrial Tumors, including STUMP and Sarcoma – Section: Ultrasound features of malignant myometrial pathology (STUMP and sarcoma)
6
PubMed Central. Uterine Myomas and Sarcomas – Clinical and Ultrasound Characteristics and Differential Diagnosis Using Pulsed and Color Doppler Techniques
7
PubMed. Deep Learning Radiomics Model Based on Ultrasound Images Predicts Myometrial Infiltration of Endometrial Cancer
8
PubMed. Transient non-cyclical activity of external myometrium should be considered to avoid errors in diagnosis of adenomyosis and uterine anomalies
9
PubMed Central. MRI for adenomyosis: a pictorial review
10
PubMed Central. The Significance of MRI Evaluation of the Uterine Junctional Zone in the Early Diagnosis of Adenomyosis
11
PubMed. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology
12
PubMed Central. Role of 3D Ultrasound and Doppler in Differentiating Clinically Suspected Cases of Leiomyoma and Adenomyosis of Uterus
13
PubMed. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis
14
PubMed Central. Adenomyosis in Pregnancy—Should It Be Managed in High-Risk Obstetric Units?
15
PubMed Central. Effects of adenomyosis and endomyometrial junctional zone on spontaneous preterm labor: a case-control study
16
PubMed. Ultrasound Findings After Uterine Artery Embolisation: Pictorial Essay and Clinical Validation
17
PubMed Central. The Impact of Hormone Replacement Therapy on Endometrial Pathology: A Retrospective Observational Study